Adar1 Capital Management, LLC Ikena Oncology, Inc. Transaction History
Adar1 Capital Management, LLC
- $530 Billion
- Q2 2024
A detailed history of Adar1 Capital Management, LLC transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 46,685 shares of IKNA stock, worth $79,364. This represents 0.01% of its overall portfolio holdings.
Number of Shares
46,685
Previous 35,000
33.39%
Holding current value
$79,364
Previous $49.7 Million
54.99%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding IKNA
# of Institutions
72Shares Held
31.4MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$8.53 Million1.1% of portfolio
-
Bvf Inc San Francisco, CA4.77MShares$8.11 Million0.24% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$6.95 Million2.8% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$6.02 Million0.14% of portfolio
-
Omega Fund Management, LLC Boston, MA2.25MShares$3.82 Million4.84% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $61.6M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...